Liquid chromatography-mass spectrometry (LC-MS) was used to perform comprehensive, nontargeted metabolomic profiling on serum ...
Think Type 2 diabetes is just one disease? Cutting-edge research reveals it’s actually four — and thanks to machine learning, ...
A breakthrough in microbiome research could change how colorectal cancer is detected—no colonoscopy required. Scientists used AI to map gut bacteria at an unprecedented level of detail, revealing ...
A machine learning model predicts low-density lipoprotein cholesterol from routine lab data, offering a low-cost way to ...
In early April 2026, Regeneron Pharmaceuticals received U.S. FDA approval to extend EYLEA HD dosing intervals up to every 20 ...
Read more about Wearable AI biosensors could redefine early disease detection and personalized care on Devdiscourse ...
By observing how health data changes over time, artificial intelligence can help identify “tipping points” when a patient’s ...
Highlights from dyslipidemia research presented at the American College of Cardiology Scientific Sessions 2026, focusing on ...
Joe Scott on MSNOpinion
School was built for another world - and AI is making the problem harder to ignore
At first glance, AI makes traditional learning look outdated. Why memorize facts, practice formulas, or struggle through ...
Eli Lilly signs a landmark $2.75 billion deal with Insilico Medicine to harness AI for next-generation drug discovery, gaining exclusive rights to preclinical oral therapies and access to a powerful ...
A novel glioblastoma therapy developed by Rosalind Franklin University Helix 51 incubator company UP Oncolytics showed encouraging preclinical results in two studies presented at the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results